cathepsin inhibitors (Albert Ludwigs University)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Namecathepsin inhibitors (Albert Ludwigs University)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionCathepsin B inhibitorsCathepsin L inhibitors
TargetsCathepsin LCathepsin B
Therapy Area/IndicationsMyocardial InfarctionMuscular DystrophiesOsteoporosis +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKlinikum der Albert-Ludwigs Universitaet Freiburg
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKlinikum der Albert-Ludwigs Universitaet Freiburg
Active IndicationsN/A
Inactive IndicationsMyocardial InfarctionMuscular DystrophiesOsteoporosis +[4] 

Other Information

ATC CodeN/A
Related LinksN/A